Trade ParkwayLife Reit - C2PUsg CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
| Spread | 0.034 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.021226% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000692% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | SGD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Singapore | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
Parkway Life Real Estate Investment Trust ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
| Prev. Close* | 3.598 |
| Open* | 3.588 |
| 1-Year Change* | -13.87% |
| Day's Range* | 3.588 - 3.598 |
| 52 wk Range | 3.59-4.81 |
| Average Volume (10 days) | 260.61K |
| Average Volume (3 months) | 9.70M |
| Market Cap | 2.29B |
| P/E Ratio | 58.09 |
| Shares Outstanding | 605.00M |
| Revenue | 144.20M |
| EPS | 0.07 |
| Dividend (Yield %) | 3.41755 |
| Beta | 0.16 |
| Next Earnings Date | Nov 17, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 28, 2023 | 3.598 | 0.000 | 0.00% | 3.598 | 3.608 | 3.588 |
| Sep 27, 2023 | 3.598 | -0.040 | -1.10% | 3.638 | 3.638 | 3.588 |
| Sep 26, 2023 | 3.638 | -0.019 | -0.52% | 3.657 | 3.667 | 3.628 |
| Sep 25, 2023 | 3.677 | 0.000 | 0.00% | 3.677 | 3.697 | 3.657 |
| Sep 22, 2023 | 3.657 | 0.000 | 0.00% | 3.657 | 3.667 | 3.648 |
| Sep 21, 2023 | 3.677 | -0.020 | -0.54% | 3.697 | 3.697 | 3.667 |
| Sep 20, 2023 | 3.697 | 0.000 | 0.00% | 3.697 | 3.697 | 3.647 |
| Sep 19, 2023 | 3.687 | 0.000 | 0.00% | 3.687 | 3.737 | 3.687 |
| Sep 18, 2023 | 3.727 | -0.020 | -0.53% | 3.747 | 3.767 | 3.717 |
| Sep 15, 2023 | 3.717 | -0.010 | -0.27% | 3.727 | 3.737 | 3.707 |
| Sep 14, 2023 | 3.737 | 0.010 | 0.27% | 3.727 | 3.747 | 3.717 |
| Sep 13, 2023 | 3.727 | -0.030 | -0.80% | 3.757 | 3.757 | 3.727 |
| Sep 12, 2023 | 3.737 | 0.000 | 0.00% | 3.737 | 3.747 | 3.737 |
| Sep 11, 2023 | 3.737 | -0.020 | -0.53% | 3.757 | 3.757 | 3.727 |
| Sep 8, 2023 | 3.757 | 0.010 | 0.27% | 3.747 | 3.757 | 3.737 |
| Sep 7, 2023 | 3.747 | -0.010 | -0.27% | 3.757 | 3.767 | 3.747 |
| Sep 6, 2023 | 3.767 | 0.010 | 0.27% | 3.757 | 3.767 | 3.747 |
| Sep 5, 2023 | 3.757 | -0.030 | -0.79% | 3.787 | 3.787 | 3.727 |
| Sep 4, 2023 | 3.767 | -0.070 | -1.82% | 3.837 | 3.847 | 3.767 |
| Aug 31, 2023 | 3.837 | -0.010 | -0.26% | 3.847 | 3.847 | 3.827 |
ParkwayLife Reit Events
| Time (UTC) | Country | Event |
|---|---|---|
| Friday, November 17, 2023 | ||
| Time (UTC) 00:30 | Country SG
| Event Q3 2023 Parkway Life Real Estate Investment Trust Earnings Release Q3 2023 Parkway Life Real Estate Investment Trust Earnings ReleaseForecast -Previous - |
| Friday, January 26, 2024 | ||
| Time (UTC) 00:30 | Country SG
| Event Q4 2023 Parkway Life Real Estate Investment Trust Earnings Release Q4 2023 Parkway Life Real Estate Investment Trust Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total revenue | 129.972 | 120.705 | 120.892 | 115.222 | 112.838 |
| Revenue | 129.972 | 120.705 | 120.892 | 115.222 | 112.838 |
| Cost of Revenue, Total | 25.18 | 25.696 | 24.75 | 21.952 | 22.02 |
| Gross Profit | 104.792 | 95.009 | 96.142 | 93.27 | 90.818 |
| Total Operating Expense | 21.781 | 23.75 | 25.871 | 22.056 | 21.023 |
| Interest Expense (Income) - Net Operating | -3.399 | -1.946 | -0.097 | 0.104 | -0.997 |
| Other Operating Expenses, Total | 0 | 1.218 | |||
| Operating Income | 108.191 | 96.955 | 95.021 | 93.166 | 91.815 |
| Interest Income (Expense), Net Non-Operating | -59.741 | 243.916 | 1.48 | 38.851 | 68.899 |
| Net Income Before Taxes | 48.217 | 340.752 | 96.389 | 132.004 | 160.713 |
| Net Income After Taxes | 41.136 | 331.878 | 87.224 | 123.397 | 151.932 |
| Net Income Before Extra. Items | 41.136 | 331.878 | 87.224 | 123.397 | 151.932 |
| Net Income | 41.136 | 331.878 | 87.224 | 123.397 | 151.932 |
| Income Available to Common Excl. Extra. Items | 41.136 | 331.878 | 87.224 | 123.397 | 151.932 |
| Income Available to Common Incl. Extra. Items | 41.136 | 331.878 | 87.224 | 123.397 | 151.932 |
| Diluted Net Income | 41.136 | 331.878 | 87.224 | 123.397 | 151.932 |
| Diluted Weighted Average Shares | 605.002 | 605.002 | 605.002 | 605.002 | 605.002 |
| Diluted EPS Excluding Extraordinary Items | 0.06799 | 0.54856 | 0.14417 | 0.20396 | 0.25113 |
| Dividends per Share - Common Stock Primary Issue | 0.12736 | 0.12434 | 0.12196 | 0.11608 | 0.11307 |
| Diluted Normalized EPS | 0.06799 | 0.54856 | 0.14417 | 0.20396 | 0.25113 |
| Other, Net | -0.233 | -0.119 | -0.112 | -0.013 | -0.001 |
| Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Sep 2021 | |
|---|---|---|---|---|---|
| Total revenue | 74.402 | 69.797 | 60.175 | 30.606 | 30.534 |
| Revenue | 74.402 | 69.797 | 60.175 | 30.606 | 30.534 |
| Cost of Revenue, Total | 13.425 | 12.389 | 12.791 | 6.489 | 7.357 |
| Gross Profit | 60.977 | 57.408 | 47.384 | 24.117 | 23.177 |
| Total Operating Expense | 9.846 | 10.696 | 11.085 | 6.217 | 6.876 |
| Interest Expense (Income) - Net Operating | -3.579 | -1.693 | -1.706 | -0.272 | -0.481 |
| Other Operating Expenses, Total | 0 | ||||
| Operating Income | 64.556 | 59.101 | 49.09 | 24.389 | 23.658 |
| Interest Income (Expense), Net Non-Operating | -13.605 | -63.192 | 3.218 | 0.458 | 237.55 |
| Net Income Before Taxes | 50.951 | -4.091 | 52.308 | 24.847 | 261.208 |
| Net Income After Taxes | 47.409 | -7.935 | 49.071 | 22.435 | 259.274 |
| Net Income Before Extra. Items | 47.409 | -7.935 | 49.071 | 22.435 | 259.274 |
| Net Income | 47.409 | -7.935 | 49.071 | 22.435 | 259.274 |
| Income Available to Common Excl. Extra. Items | 47.409 | -7.935 | 49.071 | 22.435 | 259.274 |
| Income Available to Common Incl. Extra. Items | 47.409 | -7.935 | 49.071 | 22.435 | 259.274 |
| Diluted Net Income | 47.409 | -7.935 | 49.071 | 22.435 | 259.274 |
| Diluted Weighted Average Shares | 605.002 | 605.002 | 605.002 | 605.002 | 605.002 |
| Diluted EPS Excluding Extraordinary Items | 0.07836 | -0.01312 | 0.08111 | 0.03708 | 0.42855 |
| Dividends per Share - Common Stock Primary Issue | 0.06454 | 0.06499 | 0.06237 | 0.03159 | 0.03149 |
| Diluted Normalized EPS | 0.07836 | -0.01312 | 0.08111 | 0.03708 | 0.42855 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Current Assets | 74.57 | 39.048 | 71.59 | 33.869 | 33.357 |
| Cash and Short Term Investments | 40.01 | 25.793 | 22.658 | 21.87 | 21.832 |
| Cash | 21.87 | 21.832 | |||
| Total Receivables, Net | 14.502 | 11.146 | 16.972 | 10.955 | 10.492 |
| Accounts Receivable - Trade, Net | 11.796 | 11.017 | 16.809 | 10.774 | 10.308 |
| Prepaid Expenses | 1.095 | 1.551 | 1.088 | 1.016 | 0.719 |
| Other Current Assets, Total | 18.963 | 0.558 | 30.872 | 0.028 | 0.314 |
| Total Assets | 2342.15 | 2345.14 | 2066.97 | 2003.03 | 1894.13 |
| Long Term Investments | 2205.88 | 2290.75 | 1991.02 | 1966.14 | 1860.53 |
| Note Receivable - Long Term | |||||
| Other Long Term Assets, Total | 61.698 | 15.337 | 4.362 | 3.018 | 0.237 |
| Total Current Liabilities | 81.17 | 117.604 | 192.779 | 102.894 | 22.153 |
| Accounts Payable | 6.572 | 6.059 | 6.042 | 5.815 | 5.649 |
| Payable/Accrued | 6.532 | 8.329 | 7.258 | 7.623 | 7.438 |
| Accrued Expenses | 0.835 | 0.461 | 0.471 | 1.085 | 0.601 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 56.65 | 94.733 | 163.036 | 77.759 | 0 |
| Other Current Liabilities, Total | 10.581 | 8.022 | 15.972 | 10.612 | 8.465 |
| Total Liabilities | 931.663 | 910.429 | 883.356 | 821.179 | 757.735 |
| Total Long Term Debt | 795.238 | 733.274 | 630.615 | 664.415 | 683.183 |
| Long Term Debt | 793.154 | 731.176 | 628.502 | 662.288 | 683.183 |
| Deferred Income Tax | 35.769 | 38.331 | 37.658 | 32.598 | 28.955 |
| Other Liabilities, Total | 19.486 | 21.22 | 22.304 | 21.272 | 23.444 |
| Total Equity | 1410.49 | 1434.71 | 1183.61 | 1181.85 | 1136.39 |
| Common Stock | 606.796 | 619.138 | 632.326 | 646.484 | 659.492 |
| Retained Earnings (Accumulated Deficit) | 799.096 | 809.93 | 550.048 | 530.704 | 473.736 |
| Other Equity, Total | 4.594 | 5.639 | 1.241 | 4.66 | 3.165 |
| Total Liabilities & Shareholders’ Equity | 2342.15 | 2345.14 | 2066.97 | 2003.03 | 1894.13 |
| Total Common Shares Outstanding | 605.002 | 605.002 | 605.002 | 605.002 | 605.002 |
| Cash & Equivalents | 40.01 | 25.793 | 22.658 | ||
| Capital Lease Obligations | 2.084 | 2.098 | 2.113 | 2.127 |
| Dec 2022 | Jun 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|
| Total Current Assets | 74.57 | 42.464 | 39.048 | 50.9 | 44.351 |
| Cash and Short Term Investments | 40.01 | 29.558 | 25.793 | 36.97 | 30.023 |
| Cash & Equivalents | 40.01 | 29.558 | 25.793 | 36.97 | 30.023 |
| Total Receivables, Net | 15.597 | 11.522 | 12.697 | 13.187 | 13.232 |
| Accounts Receivable - Trade, Net | 15.597 | 11.522 | 12.697 | 13.187 | 13.232 |
| Other Current Assets, Total | 18.963 | 1.384 | 0.558 | 0.743 | 1.096 |
| Total Assets | 2342.15 | 2261.22 | 2345.14 | 2329.16 | 2020.18 |
| Long Term Investments | 2205.88 | 2187.66 | 2290.75 | 2267.67 | 1965.21 |
| Other Long Term Assets, Total | 61.698 | 31.098 | 15.337 | 10.38 | 10.611 |
| Total Current Liabilities | 81.17 | 79.655 | 117.604 | 279.39 | 138.506 |
| Payable/Accrued | 23.697 | 16.463 | 21.917 | 22.587 | 19.427 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 56.65 | 62.331 | 94.733 | 256.189 | 118.499 |
| Other Current Liabilities, Total | 0.823 | 0.861 | 0.954 | 0.614 | 0.58 |
| Total Liabilities | 931.663 | 804.044 | 910.429 | 892.442 | 822.101 |
| Total Long Term Debt | 795.238 | 671.888 | 733.274 | 554.002 | 627.071 |
| Long Term Debt | 793.154 | 669.797 | 731.176 | 551.9 | 624.965 |
| Capital Lease Obligations | 2.084 | 2.091 | 2.098 | 2.102 | 2.106 |
| Deferred Income Tax | 35.769 | 34.268 | 38.331 | 37.932 | 36.964 |
| Other Liabilities, Total | 19.486 | 18.233 | 21.22 | 21.118 | 19.56 |
| Total Equity | 1410.49 | 1457.18 | 1434.71 | 1436.72 | 1198.07 |
| Other Equity, Total | 1410.49 | 1457.18 | 1434.71 | 1436.72 | 1198.07 |
| Total Liabilities & Shareholders’ Equity | 2342.15 | 2261.22 | 2345.14 | 2329.16 | 2020.18 |
| Total Common Shares Outstanding | 605.002 | 605.002 | 605.002 | 605.002 | 605.002 |
| Note Receivable - Long Term | 0.21 |
- Annual
- Quarterly
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 48.217 | 340.752 | 96.389 | 132.004 | 160.713 |
| Cash From Operating Activities | 94.632 | 89.862 | 90.312 | 89.248 | 88.35 |
| Non-Cash Items | 47.806 | -243.02 | -1.632 | -39.099 | -68.904 |
| Cash Taxes Paid | 4.137 | 5.525 | 5.065 | 4.945 | 4.599 |
| Cash Interest Paid | 5.693 | 4.776 | 6.751 | 6.572 | 6.749 |
| Changes in Working Capital | -1.391 | -7.87 | -4.445 | -3.657 | -3.459 |
| Cash From Investing Activities | -125.184 | -74.988 | -28.575 | -61.141 | -27.776 |
| Other Investing Cash Flow Items, Total | -125.184 | -74.988 | -28.575 | -61.141 | -27.776 |
| Cash From Financing Activities | 47.753 | -9.981 | -61.464 | -28.442 | -64.709 |
| Financing Cash Flow Items | -5.693 | -4.776 | -6.751 | -6.572 | -6.749 |
| Total Cash Dividends Paid | -64.312 | -85.184 | -82.038 | -79.437 | -78.469 |
| Issuance (Retirement) of Debt, Net | 117.758 | 79.979 | 27.325 | 57.567 | 20.509 |
| Foreign Exchange Effects | -2.984 | -1.758 | 0.515 | 0.373 | 0.505 |
| Net Change in Cash | 14.217 | 3.135 | 0.788 | 0.038 | -3.63 |
| Dec 2022 | Jun 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 48.217 | 52.308 | 340.752 | 315.905 | 54.697 |
| Cash From Operating Activities | 94.632 | 44.029 | 89.862 | 66.061 | 39.906 |
| Non-Cash Items | 47.806 | -3.218 | -243.02 | -243.339 | -5.789 |
| Cash Taxes Paid | 4.137 | 2.195 | 5.525 | 4.467 | 3.276 |
| Cash Interest Paid | 5.693 | 2.874 | 4.776 | 2.775 | 2.489 |
| Changes in Working Capital | -1.391 | -5.061 | -7.87 | -6.505 | -9.002 |
| Cash From Investing Activities | -125.184 | -8.066 | -74.988 | -29.569 | 31.857 |
| Other Investing Cash Flow Items, Total | -125.184 | -8.066 | -74.988 | -29.569 | 31.857 |
| Cash From Financing Activities | 47.753 | -28.6 | -9.981 | -20.563 | -62.888 |
| Financing Cash Flow Items | -5.693 | -2.874 | -4.776 | -2.775 | -2.489 |
| Total Cash Dividends Paid | -64.312 | -21.599 | -85.184 | -63.646 | -43.197 |
| Issuance (Retirement) of Debt, Net | 117.758 | -4.127 | 79.979 | 45.858 | -17.202 |
| Foreign Exchange Effects | -2.984 | -3.598 | -1.758 | -1.617 | -1.51 |
| Net Change in Cash | 14.217 | 3.765 | 3.135 | 14.312 | 7.365 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
ParkwayLife Reit Company profile
About Parkway Life REIT
Parkway Life Real Estate Investment Trust is a Singapore-based healthcare real estate investment trust (REIT). The principal activity of the Company is to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region, including Singapore that are used primarily for healthcare and/or healthcare-related purposes, including hospitals, healthcare facilities and real estate and/or real estate assets used for healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices. Its segments include Hospital Properties, Nursing Home and Care Facility Properties and Medical Centre Units. Its portfolio includes about 56 properties. Its properties include Mount Elizabeth Hospital Property, Gleneagles Hospital Property, Parkway East Hospital Property, Bon Sejour Yokohama Shin-Yamashita, Palmary Inn Akashi, Sompo no le Nakasyo, Maison des Centenaire Haruki and Hapine Fukuoka Noke, among others.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Parkway Life REIT revenues decreased less than 1% to SP$120.7M. Net income increased from SP$87.2M to SP$331.9M. Revenues reflect Hospital and Medical Centre segment increase of 1% to SP$70.7M, Singapore segment increase of 1% to SP$70.4M, also reflect Pharmaceutical Manufacturing and Distribution Facility segment decrease of 93% to SP$128K, Japan segment decrease of 2% to SP$50M.
Equity composition
11/2009, Capital repayment of SGD 0.0014 01/2010, Capital repayment of SGD 0.0018 05/2010, Capital repayment of SGD 0.0029 08/2010, Capital repayment of SGD .003 11/2010, Capital repayment of SGD .0044 01/2011, Capital repayment of SGD .0044
| Industry: | Healthcare REITs |
80 Robinson Road
#02-00
068898
SG
Income Statement
- Annual
- Quarterly
News
How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com